Key result
Urokinase cleavage increases thrombopoietin activity in vitro whereas plasmin cleavage markedly decreases it.
Why the study?
Limited proteolysis of full-length human thrombopoietin may be important for its biology, but the effects of different proteases on Tpo activity are not fully understood.
Urokinase and plasmin differentially modulate thrombopoietin activity through specific proteolytic cleavage sites, suggesting potential mechanisms for in vivo regulation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for proteolytic thrombopoietin regulation; in vivo studies required before clinical consideration.
Several observations suggest that limited proteolysis of full-length 70 kD human thrombopoietin (Tpo) may be important for Tpo biology. Recently, it was reported that thrombin cleaves full-length recombinant human Tpo (rhTpo) sequentially at two sites, Arg(195) within the glycan domain followed by Arg(117) within the cytokine domain, and that these cleavages modulate Tpo activity in vitro. We demonstrate that urokinase and plasmin also cleave rhTpo in a time-dependent manner. Urokinase cleavage is confined to the glycan domain, and generates a 35 kD N-terminal fragment that contains the intact cytokine domain, and is associated with increased Tpo activity. In contrast, plasmin cleaves Tpo sequentially at two specific sites (Arg(205) within the glycan domain followed by Lys(52) within the cytokine domain), and is associated with a marked decrease in Tpo activity. These proteolytic events have potential implications for regulation of Tpo activity in vivo.
No takes yet. Share an insight, caveat, or question.
A 2000 study studied this question. Urokinase and plasmin was evaluated on Thrombopoietin activity modulation. Urokinase cleavage of recombinant human thrombopoietin increased its activity, whereas plasmin cleavage markedly decreased its activity in vitro.
Synapse has enriched 10 related papers. Consider them for comparative context: